Purchase Order 75N92B26P00006
- Not listed
- Becton, Dickinson and Company, through its BDB Division operating as BD Biosciences, received a $24,942.30 firm fixed-price purchase order award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD), a component of the National Institutes of Health. The contract, awarded on December 23, 2025, with an ultimate completion date of December 22, 2026, will be performed in San Jose, California. This award was made on a full and open competition basis without a small...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, was awarded a $22,107.60 firm fixed-price purchase order by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) on December 23, 2025, with an ultimate completion date of December 22, 2026. The contract was awarded without a set-aside designation and will be performed in San Jose, California. As a global medical technology manufacturer specializing in flow cytometry systems,...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, was awarded a $11,955.60 firm fixed price maintenance contract by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) on June 15, 2024, with an ultimate completion date of December 14, 2024. The contract, issued as a Blanket Purchase Agreement (BPA) call, covers maintenance services for FACSCELESTA equipment at the performance location in Bethesda, Maryland. No small...
- Becton, Dickinson and Company (BD), through its BD Biosciences division, has been awarded an 11-month firm fixed price purchase order valued at $200,435.84 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract is for various equipment and laser services to be performed at the agency's facility in Bethesda, Maryland. No set-aside designation was applied to this solicitation. As the prime contractor, BD will leverage its expertise providing...
- Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, received a $22,500 firm fixed-price contract award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) on December 19, 2019. This contract call was issued under a Blanket Purchase Agreement (BPA) with an ultimate completion date of December 31, 2019, and was awarded without a small business set-aside designation. The work is to be performed in Bethesda, Maryland, where...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, received a Firm Fixed Price Blanket Purchase Agreement (BPA) call valued at $21,587.40 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health. The contract was awarded on February 8, 2019, with an ultimate completion date of July 31, 2019, for performance at the NIH campus in Bethesda, Maryland. No small business set-aside was...
- Becton, Dickinson and Company, through its BD Biosciences division, was awarded a $22,613.40 firm fixed-price contract call under a Blanket Purchase Agreement by the National Institute of Arthritis and Musculoskeletal and Skin Diseases for the provision of scientific instruments and related services. The contract, awarded on March 11, 2020, with an ultimate completion date of August 31, 2020, will support the institute's research operations at its Bethesda, Maryland facility. No small business...
- Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, was awarded a Blanket Purchase Agreement (BPA) call contract valued at $14,942.85 by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD), a component of the National Institutes of Health. The contract, awarded on August 24, 2012, with an ultimate completion date of March 31, 2013, was issued on a firm fixed-price basis without a small business set-aside designation....
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, was awarded a $21,578.76 Firm Fixed Price Blanket Purchase Agreement (BPA) call for maintenance services on a FACSymphony A3 flow cytometry instrument by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health. The contract, awarded on June 15, 2024, with an ultimate completion date of December 14, 2024, will be performed at the...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, received a contract award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) for $8,217.50. This Blanket Purchase Agreement (BPA) call was awarded on December 18, 2015, with a completion date of December 31, 2015, utilizing firm fixed-price pricing. The contract involved no small business set-aside designation and was performed in Bethesda, Maryland. As a child entity...
Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, was awarded a purchase order valued at $24,924.63 by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD), a component of the National Institutes of Health. The contract, awarded on December 30, 2025, covers a period of performance from December 29, 2025, through July 16, 2026, with an ultimate completion date of July 17, 2026. The award encompasses service contracts for multiple flow cytometry instruments, including FACSymphony A3, OBIS 405-100 LX Violet Laser, and G4 355-20 UV Laser systems. The contract was awarded on a firm fixed-price basis with no small business set-aside designation, reflecting BD's competitive positioning in the federal medical technology marketplace. The place of performance is San Jose, California. This purchase order represents routine maintenance and support services for sophisticated flow cytometry equipment that supports critical biomedical research at NIAMSD facilities. BD Biosciences has established itself as a primary provider of flow cytometry instruments and associated technical support services across multiple NIH components and federal agencies. The relatively modest contract value reflects the service nature of the award rather than equipment procurement, consistent with BD's extensive portfolio of maintenance and support contracts that enable federal healthcare and research institutions to maintain advanced laboratory capabilities essential to their research missions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.9k | 12/30/25 |